<DOC>
	<DOCNO>NCT01883024</DOCNO>
	<brief_summary>The purpose study assess relevance advice provide IPRA© smartphone application guide response insulin pump treat type 1 diabetes patient use real-time continuous glucose monitoring .</brief_summary>
	<brief_title>Insulin Pump-RT Advisor ( IPRA© ) : Decision Support Software Diabetic Patients Treated Insulin Pump Using Continuous Glucose Monitoring . Experimental Study . Evaluation Expert Patient Panel .</brief_title>
	<detailed_description>Patients ask evaluate IPRA advice connect IPRA© application use smartphone , 30 time week two week . At end two week period , satisfaction questionnaire complete .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>men woman ≥ 18 year age , patient type 1 diabetes 2 year , patient treat insulin pump 6 month , patient use realtime continuous glucose monitor 3 month , patient able evaluate IPRA advice connect IPRA© application 30 time week , patient able provide write informed consent , patient able provide write nondisclosure agreement pregnancy breastfeeding , current infectious disease , patient smartphone® Internet access , adult legally protect ( judicial protection , guardianship , supervision ) , person deprive liberty</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Real time continuous glucose monitoring , decision support software , smartphone application .</keyword>
</DOC>